Search Results
Apr 16, 2026, 13:12 ET Piramal Pharma Solutions und Ajinomoto Bio-Pharma Services arbeiten zusammen, um die Entwicklung und Herstellung von ADCs zu unterstützen
16. April 2026 /PRNewswire/ -- Piramal Pharma Solutions, ein weltweit führendes Unternehmen für Auftragsentwicklung und -herstellung (CDMO) und Teil von Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), und Ajinomoto Bio-Pharma Services („Aji Bio-Pharma"), ein führender Anbieter
More news about: Piramal Pharma Solutions
Apr 16, 2026, 08:30 ET Piramal Pharma Solutions y Ajinomoto Bio-Pharma Services colaboran en el desarrollo y fabricación de ADC
16 de abril de 2026 /PRNewswire/ -- Piramal Pharma Solutions, una organización líder mundial en desarrollo y fabricación por contrato (CDMO, por sus siglas en inglés) y parte de Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), y Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), un proveedor
More news about: Piramal Pharma Solutions
Apr 16, 2026, 08:00 ET Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing
April 16, 2026 /PRNewswire/ -- Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), and Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of
More news about: Piramal Pharma Solutions
Apr 16, 2026, 08:00 ET Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing
April 16, 2026 /PRNewswire/ -- Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), and Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of
More news about: Piramal Pharma Solutions
Apr 16, 2026, 08:00 ET Crystal Pharmatech Becomes First Company in Asia-Pacific to Deploy Dedicated MicroED Platform Through Strategic Collaboration with ELDICO Scientific
SUZHOU, China, April 16, 2026 /PRNewswire/ -- Crystal Pharmatech is a science-driven CRO/CDMO specializing in solid-state research, preformulation studies, and formulation development and manufacturing for small molecule drugs. The company operates
More news about: Crystal Pharmatech
Apr 16, 2026, 03:07 ET BIO Asia-Taiwan 2026 to Be Held in Mid-July in Taipei
alignment) to create a full lifecycle acceleration platform, from early R&D and clinical trials to manufacturing and market entry. By leveraging AI, CDMO/CRO ecosystems, capital investment, and regulatory harmonization, the time to bring new drugs to market could be shortened by 5 to 7 years, she reported.The
More news about: Taiwan Bio Industry Organization
Apr 15, 2026, 08:30 ET SQ Innovation and FIS Announce Strategic Supply Agreement for Furosemide API
and production of Active Pharmaceutical Ingredients (APIs) for the global pharmaceutical industry, standing out as an international benchmark in the CDMO (Contract Development and Manufacturing Organization) sector. FIS operates through three plants in Italy (Montecchio Maggiore, Termoli and Lonigo),
More news about: SQ Innovation
Apr 15, 2026, 08:00 ET Tivic Health Selected to Present Entolimod™ as a Radiation Countermeasure and its Plans for an Oral Transmucosal Program to the Department of War Tech Watch Program on May 7th
known as lymphocyte exhaustion. Tivic's wholly owned subsidiary, Velocity Bioworks, is a full-service contract development manufacturing organization (CDMO) offering biomanufacturing services to third-party biotech companies. Tivic also leverages Velocity Bioworks' manufacturing capabilities to advance
More news about: Tivic Health Systems, Inc.
Apr 14, 2026, 15:34 ET M&A Activity Sees Healthy Boost in the Vitamins, Minerals, and Supplements Market
takeaways include:Assessment of the market size and growth profile of the Contract Development & Manufacturing Organization (CDMO) market and the increasingly strategic role these organizations are assuming within the modern VMS value chainHow consumer
More news about: Brown Gibbons Lang & Company
Apr 14, 2026, 14:34 ET Apotex Announces Strategic U.S. Sterile Filling Partnership with Halo Pharmaceuticals
of Halo Pharmaceuticals. "We will still have ample capacity available for other customers who require vial, syringe, and cartridge sterile filling CDMO services."About ApotexApotex Corp., headquartered in Weston, Florida, is an affiliate of Apotex Inc. We improve everyday access
More news about: Apotex Corp.
Apr 14, 2026, 13:57 ET Global CMO/CDMO Market Set for Steady Growth as Biologics Outsourcing and Specialized Manufacturing Drive Demand | Future Market Insights (FMI)
CMO/CDMO market is witnessing consistent expansion as pharmaceutical and biotech companies increasingly outsource development and manufacturing to focus on core competencies amid rising drug complexity and cost pressures. The CMO/CDMO Market was valued at USD 4.02
More news about: Future Market Insights
Apr 14, 2026, 10:00 ET TCI Biotech Returns to Vitafoods Europe 2026 with Five Provocations for the Nutraceutical Industry and a Glimpse of the Future
BARCELONA, Spain, April 14, 2026 /PRNewswire/ -- TCI Biotech, the global CDMO+ leader in health and wellness innovation, will return to Vitafoods Europe 2026 at booth 3F40, Fira Barcelona Gran Via, armed with five bold challenges
More news about: TCI; TCI Biotech
Apr 14, 2026, 10:00 ET UPSHER-SMITH LAUNCHES NEW ONLINE RESOURCES TO SUPPORT THE DUCHENNE COMMUNITY
services company with a vision and goal of "Contributing to Better Health All Over the World". Operating under a "Dual Engine" model that integrates CDMO and commercial expertise, we empower pharmaceutical and biotech partners to optimize product development, accelerate launches, and scale supply to meet
More news about: Upsher-Smith Laboratories, LLC
Apr 14, 2026, 09:30 ET Asymchem Unveils Its Fully Integrated TIDES Commercial Supply Matrix - Supporting Partners from Molecule to Market
China, April 14, 2026 /PRNewswire/ -- Asymchem, a global contract development and manufacturing organization (CDMO), has unveiled an integrated commercial supply matrix for TIDES (Peptides and Oligonucleotides) at its TJ4 site, combining expanded API manufacturing
More news about: Asymchem Laboratories
Apr 14, 2026, 09:02 ET Clarity signs a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with Nucleus RadioPharma
Manufacturing Agreement for 64Cu-SAR-bisPSMA with Nucleus RadioPharma, an innovative contract development and manufacturing organisation (CDMO) in the radiopharmaceutical industry, dedicated to the development and manufacturing of targeted radiotherapies.
More news about: Clarity Pharmaceuticals
Apr 14, 2026, 08:00 ET Andelyn Biosciences Partners with Evolyra Therapeutics for the Clinical Manufacturing of Gene Therapies for the Treatment of Limb-Girdle Muscular Dystrophies
2026 /PRNewswire/ -- Andelyn Biosciences, a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), announced today a partnership with Evolyra Therapeutics to manufacture clinical-grade AAV gene therapies for treating types 2C and 2D Limb-Girdle Muscular
More news about: Andelyn Biosciences
Apr 14, 2026, 08:00 ET Flow Sciences Appoints Kent Lupino as Chief Marketing Officer
of marketing and sales operations at Tergus Pharma, a Durham, N.C.-based topical pharmaceutical contract development and manufacturing organization (CDMO) that merged with MedPharm Ltd. in 2024. Earlier in his career he held marketing and product management leadership roles at BioMedomics, Inc., SunTech
More news about: Flow Sciences Inc
Apr 09, 2026, 02:42 ET Global Fine Chemicals Market Trends 2026-2036: Regional Growth Strategies from Sumitomo Chemical to IPCA Laboratories | Future Market Insights, Inc.
in:Advanced API and biologic intermediate synthesisGreen chemistry and sustainable processing technologiesCDMO partnerships and outsourcing modelsLocalization strategies in emerging economiesCompanies investing in digital GMP compliance,
More news about: Future Market Insights
Apr 08, 2026, 09:00 ET Altruist Biologics' Hangzhou Facility Secures First Commercial Manufacturing License
2026 /PRNewswire/ -- Altruist Biologics, an Innovent Biologics subsidiary and world-class contract development and manufacturing organization (CDMO), announced that its Hangzhou facility was granted the Drug Product Manufacturing License (C Certificate) from the Chinese National Medical Products
More news about: Altruist Biologics
Apr 08, 2026, 09:00 ET Altruist Biologics' Hangzhou Facility Secures First Commercial Manufacturing License
2026 /PRNewswire/ -- Altruist Biologics, an Innovent Biologics subsidiary and world-class contract development and manufacturing organization (CDMO), announced that its Hangzhou facility was granted the Drug Product Manufacturing License (C Certificate) from the Chinese National Medical Products
More news about: Altruist Biologics
Apr 07, 2026, 12:27 ET ANA Global Appoints MedTech Industry Veteran Mike Sanford as Chief Commercial Officer to Drive Strategic Growth
evolving needs of global OEMs.A seasoned executive with over 20 years of leadership in the medical device contract design and manufacturing (CDMO) industry, Sanford has an established track record of driving commercial excellence for global market leaders. He joins ANA Global following Senior
More news about: ANA Global
Apr 07, 2026, 05:19 ET Fifteen Years Alongside Europe's Drug Discovery Teams: Viva Biotech Strengthens Continuity from Discovery to Development and Manufacturing
targets.Seamless Transition to Development: To eliminate the friction between discovery and manufacturing, the platform extends into CMC and CDMO services, supporting projects through to commercialization and process performance qualification (PPQ). To date, this integrated approach has supported
More news about: Viva Biotech
Apr 06, 2026, 14:01 ET UPSHER-SMITH LAUNCHES GENERIC VERSION OF CIPRODEX® (CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1%) STERILE OTIC SUSPENSION
services company with a vision and goal of "Contributing to Better Health All Over the World". Operating under a "Dual Engine" model that integrates CDMO and commercial expertise, we empower pharmaceutical and biotech partners to optimize product development, accelerate launches, and scale supply to meet
More news about: Upsher-Smith Laboratories, LLC
Apr 06, 2026, 07:00 ET Scinai Completes Strategic Reorganization to Establish Dedicated CDMO Platform and Lean R&D Structure; Outlines 2026 Priorities
consolidate CDMO activities, the Company transferred all CDMO-related operations, including employees, infrastructure, manufacturing facilities, customer contracts and associated business activities, into this entity, establishing Scinai Biopharma Services Ltd. as the Company's dedicated CDMO subsidiary.Scinai
More news about: SCINAI IMMUNOTHERAPEUTICS LTD
Apr 01, 2026, 08:50 ET Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing
www.cytovance.com), a leading full-service contract development and manufacturing organization ("CDMO") specializing in mammalian and microbially expressed biologics, to produce cGMP clinical materials for its planned Phase 2 clinical trial of its breast
More news about: Anixa Biosciences, Inc.